Episode 202: Helen Branswell on the pandemic, plus the next FDA debate & the perks of being a CEO
Are Covid-19 vaccines a sustainable business? Was…
March 24, 202235m 1s
Audio is streamed directly from the publisher (traffic.megaphone.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Are Covid-19 vaccines a sustainable business? Was Aduhelm an aberration? And what comes after Omicron?
Senior writer Helen Branswell joins us to discuss the latest twists in the pandemic, including rising case counts, next-generation vaccines, and the latest data from pediatric trials. We also dive into the latest news in the life sciences, including Moderna's grand ambitions, Al Sandrock's new job, and the next big FDA debate.